
|Articles|January 29, 2021
YPrime Launches eCOA Gen 5
Advertisement
YPrime, LLC has announced the launch of their fifth-generation electronic clinical outcome assessment (eCOA) platform. YPrime’s newest platform features an improved user experience for patients, clinical investigators, sponsors, and CROs. YPrime’s platform aims to help patients remain engaged and compliant through straightforward design. They offer a customized solution with the necessary control and security that collects data from specification to submission.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
2
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Breaking the Efficacy Ceiling in IBD and Beyond
5



